Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: Clinicopathological features, efficacy, and factors affecting survival için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: Clinicopathological features, efficacy, and factors affecting survival | 1 |
Aylık toplam ziyaret
| views | |
|---|---|
| Mayıs 2026 | 0 |
| Haziran 2026 | 1 |
| Temmuz 2026 | 0 |
| Ağustos 2026 | 0 |
| Eylül 2026 | 0 |
| Ekim 2026 | 0 |
| Kasım 2026 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| 0534.pdf | 23 |












